SC0T:XETRA:XETRA-Invesco Markets plc - Invesco STOXX Europe 600 Optimised Health Care UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 384.2

Change

0.00 (0.00)%

Market Cap

USD 0.01B

Volume

7.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-25 )

ETFs Containing SC0T:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.38% 42% F 47% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.38% 40% F 45% F
Trailing 12 Months  
Capital Gain 7.00% 44% F 48% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.00% 42% F 46% F
Trailing 5 Years  
Capital Gain 27.62% 58% F 61% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 27.62% 53% F 55% F
Average Annual (5 Year Horizon)  
Capital Gain 7.62% 55% F 56% F
Dividend Return 7.62% 54% F 54% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 8.36% 69% C- 75% C
Risk Adjusted Return 91.16% 82% B 85% B
Market Capitalization 0.01B 8% B- 7% C-

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.